IRB Study Number 24-363
Status Recruiting
Institute Endocrinology and Metabolism Institute
Description
This study is being done to test the use of a questionnaire in individualizing physical activity treatment among people who have excess weight.
Inclusion Criteria
- Age 18 or older
- Patients with BMI of > 35 at time of screening
- Report no current regular exercise (less than 3 days per week and totaling less than 90 minutes per week of structured exercise, for each of the past 4 weeks)
- Medical Clearance provided by referring MD, PCP, or study physician based on ACSM recommendations (see separate attachment 1 in the attached documents section)
- Ability to ambulate without assistance (not using a cane or wheelchair)
- English speaking
- Must be signed up with and able to frequently access MyChart.
- Must have smart phones with Apple iOS 15 and higher or Android 9 or higher which are compatible with the Fitbit software.
- Post-study evaluation to determine the utility/satisfaction from the participants and Co-Investigators and provide perspective of using the Bari-PROFILE to individualize exercise counseling and resources provided.
Exclusion Criteria
- Patients who have an implantable device or pacemaker.
- Symptomatic cardiovascular disease, need for supplemental oxygen, uncontrolled hypertension, frequent hypoglycemia, and/or orthopedic issues which present high risk of adverse events associated with structured exercise. These risks will be determined by both the referring physician and study team.
- Unwillingness or inability to continuously wear a wrist-worn physical activity device throughout the duration of the study during waking hours.
- Patients planning to have bariatric surgery during the window of intervention. (Participants may be planning to have bariatric surgery in 6 months or more and may be in the postoperative phase with eligibility considered when the patient is medically released at least one month after surgery).
- Pregnancy at time of screening.
- Any other condition which in the judgement of the investigators would preclude safe participation in the study.
